Granulocyte-colony stimulating factors for secondary prevention of leucopenia in patients receiving chemotherapy.
Article
Dans Anglais
| IMSEAR
| ID: sea-45188
ABSTRACT
OBJECTIVE:
To evaluate the effectiveness of GCSF as a secondary preventive adjunct to chemotherapy in the gynaecologic cancer patients who previously had grade 3-4 neutropenia or leucopenia from chemotherapy. MATERIAL ANDMETHOD:
We retrospectively reviewed the medical records of 94 chemotherapeutic cycles with GCSF as secondary prophylaxis in 29 patients with gynaecologic malignancy between January 1996 and April 2005.RESULTS:
The median age of the patients was 51 years (21-75). Most of the patients had ovarian cancers (19 cases, 65.6%). From secondary GCSF, grade 4 neutropenia was developed in 12 of 94 cycles (12.8%), and grade 4 leucopenia was developed in 5 of 94 cycles (5.3%). There were no patients developing febrile neutropenia after GCSF support.CONCLUSION:
Secondary GCSF prophylaxis was effective in preventing grade 4 leucopenia, grade 4 neutropenia, and febrile neutropenia.
Texte intégral:
Disponible
Indice:
IMSEAR (Asie du Sud-Est)
Sujet Principal:
Tumeurs de l'ovaire
/
Sujet âgé
/
Femelle
/
Humains
/
Facteurs de risque
/
Carboplatine
/
Facteur de stimulation des colonies de granulocytes et de macrophages
/
Cisplatine
/
Paclitaxel
/
Adulte
Type d'étude:
Etude d'étiologie
/
Facteurs de risque
langue:
Anglais
Année:
2006
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS